文献速递痛风与晶体性关节病

痛风患者十年心血管风险变化与主要不良事件

Ten-year cardiovascular risk changes and major adverse events in gout patients.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

基于韩国全国医保与健康筛查数据库的队列研究,纳入113853例新诊断痛风患者及1138530例年龄性别匹配对照。调整痛风诊断前10年心血管风险谱及其长期变化后,痛风与心肌梗死(HR 1.39)、脑梗死(HR 1.36)、脑出血(HR 1.50)及全因死亡(HR 1.07)风险升高相关。这些长期变化可叠加增加痛风患者的心血管事件风险。

要点

  • 痛风患者心肌梗死风险升高(HR 1.39,P < 0.001)。
  • 痛风患者脑梗死(HR 1.36)与脑出血(HR 1.50)风险升高,P < 0.001。
  • 痛风患者全因死亡风险轻度升高(HR 1.07,P = 0.004)。

核心结论

  • 即使调整心血管风险谱及其长期变化,痛风患者发生心血管事件的风险仍较高。
  • 这些长期变化可叠加增加痛风患者的心血管事件风险。

研究设计与样本

  • 基于韩国国民健康保险理赔数据库与国民健康筛查计划的全国性队列研究。
  • 纳入2012年1月后新诊断痛风、年龄20-90岁的患者,以及年龄和性别匹配的无痛风对照。
  • 调整痛风诊断前10年测量的心血管风险谱及其长期变化后,评估痛风患者新发心血管事件(心肌梗死、脑梗死、脑出血)及全因死亡的相对风险。

主要发现

  • 共纳入113853例痛风患者和1138530例匹配对照。
  • 多变量分析显示痛风与心肌梗死风险升高相关(HR 1.39,P < 0.001)。
  • 痛风与脑梗死风险升高相关(HR 1.36,P < 0.001)。
  • 痛风与脑出血风险升高相关(HR 1.50,P < 0.001)。
  • 痛风与全因死亡风险升高相关(HR 1.07,P = 0.004)。

关键数值与推荐

  • 心肌梗死与10年间舒张压加重1级存在显著交互作用(P = 0.042)。
  • 脑梗死与10年间舒张压加重2级存在显著交互作用(P = 0.037)。
  • 脑出血与10年间总胆固醇加重2级存在交互作用(P = 0.057)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The long-term interaction between cardiovascular (CV) risk profiles and gout may influence the risk of cardiovascular events. However, the impact of gout and long-term changes in CV risk profile on CV events is unclear. METHODS: This was a nationwide cohort study based on the Korean National Health Insurance claims database and the National Health Screening Program. Patients aged 20-90 years newly diagnosed with gout after January 2012 and age- and sex-matched controls without gout were included. After adjusting for CV risk profiles measured 10 years before gout diagnosis and their long-term changes, the relative risks of incident CV events (myocardial infarction, cerebral infarction and cerebral haemorrhage) and all-cause death in the gout patients were assessed. RESULTS: In total, 113 853 patients with gout and 1 138 530 matched controls were studied. Multivariable analysis showed that gout was associated with increased risks for myocardial infarction (hazard ratio [HR]: 1.39, P < 0.001), cerebral infarction (HR: 1.36, P < 0.001), cerebral haemorrhage (HR: 1.50, P < 0.001), and all-cause death (HR: 1.07, P = 0.004). In addition, significant interactions were observed for myocardial infarction (Grade 1 aggravation over 10 years of diastolic blood pressure [DBP], P = 0.042), cerebral infarction (Grade 2 aggravation over 10 years of DBP, P = 0.037) and cerebral haemorrhage (Grade 2 aggravation over 10 years of total cholesterol, P = 0.057). CONCLUSIONS: Gout patients had a high risk of incident CV events even after adjusting for CV risk profiles and their long-term changes. These long-term changes additively increase the risk of CV events in gout patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ghang B, Kim J, Kang T, et al. Ten-year cardiovascular risk changes and major adverse events in gout patients. Rheumatology (Oxford). 2026. PMID: 40971687. doi:10.1093/rheumatology/keaf322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。